Advertisement

Cancer Diet Shared by Healthy Cells

Tumor cells rapidly divide by usurping a metabolic trick from normal cell development.

By | January 23, 2013

WIKIMEDIA, REYTANTo fuel runaway tumor growth, cancer cells use a metabolic mechanism, called glycolysis, that normal cells were believed to only use in the absence of oxygen. But according to a study released today (January 23) in Cancer & Metabolism, certain progenitor cells use glycolysis to power rapid growth during early tissue development, even when oxygen is readily available—suggesting that tumors arise out of the normal metabolic processes for tissue growth.

“They demonstrate nicely that [aerobic glycolysis] is required in normal development,” said cancer genetics researcher Chi Van Dang, director of University of Pennsylvania’s Abramson Cancer Center, who was not involved in the study. Moreover, he adds, the study highlights the importance of tightly regulated metabolism and cell growth—whether to spur early tissue development or unbridled tumor development. Before this study, “the prevailing viewpoint was that metabolism was just along for the ride.” (Read an in-depth discussion of the role of metabolism in complex diseases in The Scientist’s 2011 feature, “Power Failure.”)

Unlike the controlled diet of normal cells that make energy from pyruvate in the presence of oxygen, cancer cells gobble up glucose and convert it to lactic acid. Why and how tumors utilize this type of metabolism even in the presence of oxygen—a phenomenon first noted in the 1920s by Otto Warburg and hence known as the Warburg effect—has long been an enigma of cancer physiology.

The first clue to solving the Warburg mystery came 10 years ago, when, working as a researcher at the Memorial Sloan-Kettering Cancer Center in New York City, pediatric neuro-oncologist Timothy Gershon and colleagues noticed something peculiar about neuron progenitor cells: when they prodded the cells in the lab, they started multiplying and the cell culture media changed colors, indicating a more acidic pH. Gershon and his colleagues assumed the changes resulted from the fact that the cells were making lactic acid, he said. But they didn’t immediately piece together the observation and the Warburg effect.

Now at the University of North Carolina, Chapel Hill (UNC), Gershon is focusing on a rare brain cancer called medulloblastoma, and has, found that both brain tumor cells and healthy, multiplying neuron progenitor cells use aerobic glycolysis. They also found that that this distinct diet requires the enzyme hexokinase-2 (HK2)—instead of HK1. Both HK1 and HK2 work to trap glucose in the cell by tagging it with phosphate, but unlike HK1, HK2 does so without any restraints. Thus, by using HK2, the cells have an endless supply of sugar, which can fuel rapid growth even when oxygen begins to run out.

When Gershon and colleagues selectively knocked out the HK2 gene in the brains of mice prone to medulloblastoma, they found that many of the mice didn’t develop the hallmark lethal brain cancer. Moreover, the tumor cells in the knockout mice transformed into normal cells. “We thought that if cells ran out of energy, they’d die,” Gershon said. “But what we actually see is that when the tumor cells are blocked in their metabolism and they can’t meet their energy needs through [aerobic] glycolysis, they differentiate into non-dividing cells.”

The findings point to HK2 targeted therapies that could one day treat medulloblastoma and other cancers, Dang said. But he cautions that the link between normal cell metabolism and tumor development may make developing such therapies more complicated. “We’re not going to get away without any side effects,” he said. The trick will be to find a window when researchers can block HK2 to stop tumor growth, but not normal development.

Additionally, Dang points out, that although the HK2-knock out mice didn’t develop lethal tumors, some did develop non-lethal brain tumors, which will require further research to understand.

Still, Gershon, who treats pediatric cases of medulloblastoma, is optimistic. “I’m encouraged that these mice didn’t drop dead when we knocked out HK2,” he said. “I think this is something that will lead to an improved therapy in the time that I’m a researcher, which would be nice to see.”

T.R. Gershon et al., “Hexokinase-2-mediated aerobic glycolysis is integral to cerebellar neurogenesis and pathogenesis of medulloblastoma,” Cancer & Metabolism, doi:10.1186/2049-3002-1-2, 2013.

Correction, 1.23.2013: The original article incorrectly stated that the HK2 knockout mice didn't develop lethal brain cancer, when it should have stated that many of the HK2 knockout mice didn't develop lethal brain cancer. The Scientist regrets the error.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Anita Lekhwani

Anita Lekhwani

Posts: 1

January 23, 2013

This result is one of the premises of a diet devised to help starve cancer cells.  It is Cancer as a Metabolic Disease: On the Origin, Management, and Prevention of Cancer written by Thomas Seyfried.  The diet described in the book is being used by cancer patients to help derive a diet that does not feed tumors the sugar they need to proliferate.  Check it out at: http://www.wiley.com/WileyCDA/WileyTitle/productCd-0470584920.html.

January 23, 2013

Good grief.  Whatever happened to our knowledge of basic metabolism?

1.  Glycolysis:  the metabolic pathway from glucose to either pyruvate or lactate.  If a cell is using glucose for energy, it employs "glycolysis." This is true whether it is undergoing aerobic or anaerobic respiration.   If it is undergoing aerobic respiration, it then subseequently uses the pyruvate to enter into the mitochondrial respiration system.  If it is not undergoing aerobic respiration, it might metabolize the pyruvate to lactate and secrete the lactate as waste.  To say that only tumor cells and embryonic cells undergo "glycolysis" is sort of ridiculous.  Glycolysis is a process of glucose catabolism that necessarily precedes aerobic respiration; it is NOT an "either-or" situation.

2.  If "only" tumor cells and embryonic cells undergo "glycolysis instead of aerobic respiration" (see point 1, above), then how would you classify actively contracting fully differentiated skeletal muscle cells?  (Hint: they secrete lactate).

It's really a pity that the contemporary training of biomedical "scientists" is so woefully inadequate.

January 23, 2013

Starving the body of glucose as a cure for cancer doesn't make sense.

ALL CELLS require glucose for energy generation, not just tumor cells.  If you starve the body of glucose, the body will convert protein to glucose for energy generation.  In cases of severe starvation, the body will break down muscle protein in order to generate glucose to keep the body going.  

Glucose is indispensible for vertebrate metabolism.  

Avatar of: Iwona Grad

Iwona Grad

Posts: 7

January 24, 2013

 

It isn`t against basic knowledge of metabolism. The idea of cancer cells being largely glycolytic is about 100 years old. As stated, it comes from the observations of Otto Warburg and is known as the Warburg effect. He has observed that cancer cells increase the rate of glycolysis and, even in the presence of oxygen, do not enter the carbon atoms derived from glucose into the Krebs cycle but release them in the form of lactate. This observation has been widely used in cancer diagnostics, in PET scans.

The question if cancer cells switch off oxidative phosphorylation is still open, some do, some don`t, some de-couple glycolysis from oxidative phosphorylation. The explanation of the phenomenon is also still an open question. The most plausible answer is meeting the energy demands together with biomass production - mathematical modeling as well as biochemical measurements point to this metabolic configuration as being optimal in this respect. 

Since I have learned about this fascinating metabolic phenomenon, I thought that she starvation of cancer cells is an interesting concept. However blood glucose levels are very tightly regulated. In the absence of sugars, glucogeogenesis is replenishing the pool, so how are you going to obtain the effect? 

Another interesting concept connect with cancer metabolism connected therapies, is sodium bicarbonate use. Since cancer cells release lactate, and it is also believed to be advantageous for their growth, change of pH was proposed as a therapeutic mean. Previously used only as an alternative treatment, it is undergoing clinical trial at the moment. 

Cancer metabolism is a very hot topic or research at the moment and this paper just adds up to the growing knowledge. However the role of hexokinase has already been investigated, as well as it was demonstrated that undifferentiated cells switch to being more glycolytic - eg in the induced reprogramming field. 

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
Mettler Toledo
Mettler Toledo

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Culture Techniques
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
ProteinSimple
ProteinSimple
Advertisement
NeuroScientistNews
NeuroScientistNews